2015

1.            Rezaeifard S, Razmkhah M, Robati M, et al. Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancer. Iranian journal of medical sciences. 2015;40(3):225-232.

2.            Razmkhah M, Abedi N, Hosseini A, et al. Induction of T Regulatory Subsets from Naive CD4+ T Cells after Exposure to Breast Cancer Adipose Derived Stem Cells. Iranian journal of immunology : IJI. 2015;12(1):1-15.

3.            Omidvari S, Zohourinia S, Ansari M, et al. Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Annals of coloproctology. 2015;31(4):123-130.

4.            Nemati K, Golmoghaddam H, Hosseini SV, et al. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression. Gene. 2015;561(1):88-94.

5.            Khosravi-Maharlooei M, Jaberipour M, Hosseini Tashnizi A, et al. Expression Pattern of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase (hTERT) in Cancer Cell Lines Was not Associated with the Origin of the Cells. International journal of molecular and cellular medicine. 2015;4(2):109-119.

6.            Khodadad M, Hosseini SY, Shenavar F, et al. Construction of expressing vectors including melanoma differentiation-associated gene-7 (mda-7) fused with the RGD sequences for better tumor targeting. Iranian journal of basic medical sciences. 2015;18(8):780-787.

7.            Haghshenas MR, Khademi B, Faghih Z, et al. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors. Immunology letters. 2015;164(2):109-116.

8.            Golestan AM, Mojtahedi ZP, Ghalamfarsa GP, et al. The Effects of NDRG2 Overexpression on Cell Proliferation and Invasiveness of SW48 Colorectal Cancer Cell Line. Iranian journal of medical sciences. 2015;40(5):430-439.

9.            Fazelzadeh Haghighi M, Ali Ghayumi M, Behzadnia F, et al. Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma. Iranian journal of basic medical sciences. 2015;18(5):465-471.

10.          Faraji SN, Mojtahedi Z, Ghalamfarsa G, et al. N-myc downstream regulated gene 2 overexpression reduces matrix metalloproteinase-2 and -9 activities and cell invasion of A549 lung cancer cell line in vitro. Iranian journal of basic medical sciences. 2015;18(8):773-779.

11.          Erfani N, Nazemosadat Z, Moein M. Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D. Pharmacognosy research. 2015;7(2):133-137.

12.          Baharlou R, Khezri A, Razmkhah M, et al. Increased interleukin-17 transcripts in peripheral blood mononuclear cells, a link between T-helper 17 and proinflammatory responses in bladder cancer. Iranian Red Crescent medical journal. 2015;17(2):e9244.

2014

1.            Ziaian B, Saberi A, Ghayyoumi MA, Safaei A, Ghaderi A, Mojtahedi Z. Association of high LDH and low glucose levels in pleural space with HER2 expression in non-small cell lung cancer. Asian Pacific journal of cancer prevention : APJCP. 2014;15(4):1617-20.

2.            Taghipour Fard Ardekani M, Malekzadeh M, Hosseini SV, Bordbar E, Doroudchi M, Ghaderi A. Evaluation of Pre-Treatment Serum Levels of IL-7 and GM-CSF in Colorectal Cancer Patients. International journal of molecular and cellular medicine. 2014;3(1):27-34.

3.            Sarvari J, Mojtahedi Z, Kuramitsu Y, Fattahi MR, Ghaderi A, Nakamura K, et al. Comparative Proteomics of Sera From HCC Patients With Different Origins. Hepatitis monthly. 2014;14(1):e13103.

4.            Sanaee MN, Malekzadeh M, Khezri A, Ghaderi A, Doroudchi M. Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer. Urologia internationalis. 2014.

5.            Rezaeifard S, Razmkhah M, Robati M, Momtahan M, Ghaderi A. Adipose derived stem cells isolated from omentum: a novel source of chemokines for ovarian cancer growth. Journal of cancer research and therapeutics. 2014;10(1):159-64.

6.            Razmkhah M, Jaberipour M, Ghaderi A. Downregulation of MMP2 and Bcl-2 in Adipose Derived Stem Cells (ASCs) following Transfection with IP-10 Gene. Avicenna journal of medical biotechnology. 2014;6(1):27-37.

7.            Razmkhah M, Habibagahi M, Alizadeh F, Hosseini A, Ghaderi A, Searle PF, et al. Synergistic anti-tumor effects of nitroreductase mutants and p53. Journal of cancer research and therapeutics. 2014;10(3):665-70.

8.            Razmkhah M, Arabpour F, Taghipour M, Mehrafshan A, Chenari N, Ghaderi A. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells. Asian Pacific journal of cancer prevention : APJCP. 2014;15(17):7201-5.

9.            Mojtahedi Z, Khademi B, Erfani N, Taregh Y, Rafati Z, Malekzadeh M, et al. Serum levels of interleukin-7 and interleukin-8 in head and neck squamous cell carcinoma. Indian journal of cancer. 2014;51(3):227-30.

10.          Khodadadi A, Razmkhah M, Eskandari AR, Hosseini A, Habibagahi M, Ghaderi A, et al. IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer. Iranian journal of medical sciences. 2014;39(4):350-6.

11.          Khaghanzadeh N, Samiei A, Ramezani M, Mojtahedi Z, Hosseinzadeh M, Ghaderi A. Umbelliprenin induced production of IFN-gamma and TNF-alpha, and reduced IL-10, IL-4, Foxp3 and TGF-beta in a mouse model of lung cancer. Immunopharmacology and immunotoxicology. 2014;36(1):25-32.

12.          Khademi B, Soleimanpour M, Ghaderi A, Mohammadianpanah M. Prognostic and predictive value of serum vascular endothelial growth factor (VEGF) in squamous cell carcinoma of the head and neck. Oral and maxillofacial surgery. 2014;18(2):187-96.

13.          Ghaderi H, Kiany F, Razmkhah M, Dadras S, Chenari N, Hosseini A, et al. mRNA expression of pattern recognition receptors and their signaling mediators in healthy and diseased gingival tissues. Journal of Indian Society of Periodontology. 2014;18(2):150-4.

14.          Faghih Z, Erfani N, Haghshenas MR, Safaei A, Talei AR, Ghaderi A. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes. Immunology letters. 2014;158(1-2):57-65.


2013

15.          Sarvari J, Mojtahedi Z, Taghavi SA, Kuramitsu Y, Shamsi Shahrabadi M, Ghaderi A, et al. Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study. Hepatitis monthly. 2013;13(7):e8351.

16.          Salimzadeh L, Jaberipour M, Hosseini A, Ghaderi A. Non-viral transfection methods optimized for gene delivery to a lung cancer cell line. Avicenna journal of medical biotechnology. 2013;5(2):68-77.

17.          Robati M, Ghaderi A, Mehraban M, Shafizad A, Nasrolahi H, Mohammadianpanah M. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts. Archives of gynecology and obstetrics. 2013;288(4):859-65.

18.          Razmkhah M, Ghaderi A. SDF-1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 2013;32(1):28-31.

19.          Razmkhah M, Ghaderi A. HLA Class I Allele Frequencies in Southern Iranian Women with Breast Cancer. Iranian journal of basic medical sciences. 2013;16(2):140-3.

20.          Mojtahedi Z, Erfani N, Malekzadeh M, Haghshenas MR, Ghaderi A, Samsami Dehaghani A. HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer. Iranian Red Crescent medical journal. 2013;15(1):1-3.

21.          Malekzadeh M, Dehaghani AS, Ghaderi A, Doroudchi M. IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma. Cancer biomarkers : section A of Disease markers. 2013;13(6):417-25.

22.          Khademi B, Ghaderi A, Hosseini SF, Niknejad N. Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma. Iranian journal of otorhinolaryngology. 2013;25(72):161-8.

23.          Hooshmand S, Ghaderi A, Yusoff K, Karrupiah T, Rosli R, Mojtahedi Z. Downregulation of RhoGDIalpha increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells. Cell adhesion & migration. 2013;7(3):297-303.

24.          Habibagahi M, Razmkhah M, Niri NM, Hosseini A, Ghaderi A, Jaberipour M. Combined 4-1BB and CD28 costimulation could unleash lymphocytes from immunosuppression induced by adipose derived stem cell soluble products. Immunological investigations. 2013;42(4):307-23.

25.          Golmoghaddam H, Arandi N, Ghaderi A, Doroudchi M. Polymorphism in Exon 2 of CD1 Genes in Southwest of Iran. Iranian journal of public health. 2013;42(7):775-82.

26.          Ghiasi N, Habibagahi M, Rosli R, Ghaderi A, Yusoff K, Hosseini A, et al. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells. Asian Pacific journal of cancer prevention : APJCP. 2013;14(11):6605-11.

27.          Faghih Z, Rezaeifard S, Safaei A, Ghaderi A, Erfani N. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression. Iranian journal of immunology : IJI. 2013;10(4):193-204.

28.          Erfani N, Khademi B, Haghshenas MR, Mojtahedi Z, Ghaderi A. Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma. Immunological investigations. 2013;42(2):81-90.

29.          Doroudchi M, Saidi M, Malekzadeh M, Golmoghaddam H, Khezri A, Ghaderi A. Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status. Future oncology (London, England). 2013;9(2):295-304.

30.          Doroudchi M, Pishe ZG, Malekzadeh M, Golmoghaddam H, Taghipour M, Ghaderi A. Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma. Asian Pacific journal of cancer prevention : APJCP. 2013;14(9):5225-30.


2012

31.          Yousefi Z, Sarvari J, Nakamura K, Kuramitsu Y, Ghaderi A, Mojtahedi Z. Secretomic analysis of large cell lung cancer cell lines using two-dimensional gel electrophoresis coupled to mass spectrometry. Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society. 2012;50(3):368-74.

32.          Toghraie F, Razmkhah M, Gholipour MA, Faghih Z, Chenari N, Torabi Nezhad S, et al. Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits. Archives of Iranian medicine. 2012;15(8):495-9.

33.          Razmkhah M, Jaberipour M, Safaei A, Talei AR, Erfani N, Ghaderi A. Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients. European cytokine network. 2012;23(3):72-7.

34.          Noori S, Monabati A, Ghaderi A. The prevalence of human papilloma virus in esophageal squamous cell carcinoma. Iranian journal of medical sciences. 2012;37(2):126-33.

35.          Motamedifar M, Saki M, Ghaderi A. Lack of association of mouse mammary tumor virus-like sequences in Iranian breast cancer patients. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2012;21(3):244-8.

36.          Mojtahedi Z, Mohmedi M, Rahimifar S, Erfani N, Hosseini SV, Ghaderi A. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer. Gene. 2012;508(2):229-32.

37.          Mojtahedi Z, Khademi B, Yehya A, Talebi A, Fattahi MJ, Ghaderi A. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma. The Journal of laryngology and otology. 2012;126(2):175-9.

38.          Khaghanzadeh N, Mojtahedi Z, Ramezani M, Erfani N, Ghaderi A. Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2012;20(1):69.

39.          Khademi B, Hashemi SB, Ghaderi A, Shahrestani A, Mohammadianpanah M. Interleukin-13 gene polymorphisms at -1055 C/T and +2044 G/A positions in patients with squamous cell carcinoma of head and neck. Brazilian journal of otorhinolaryngology. 2012;78(5):64-8.

40.          Erfani N, Moghaddasi-Sani F, Razmkhah M, Haghshenas MR, Talei A, Ghaderi A. CCL22 16C/a genetic variation is not associated with breast carcinoma in Southern Iranian population. Iranian journal of immunology : IJI. 2012;9(4):226-33.

41.          Erfani N, Mehrabadi SM, Ghayumi MA, Haghshenas MR, Mojtahedi Z, Ghaderi A, et al. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung cancer (Amsterdam, Netherlands). 2012;77(2):306-11.

42.          Erfani N, Haghshenas MR, Hoseini MA, Hashemi SB, Khademi B, Ghaderi A. Strong association of CTLA-4 variation (CT60A/G) and CTLA-4 haplotypes with predisposition of Iranians to head and neck cancer. Iranian journal of immunology : IJI. 2012;9(3):188-98.

43.          Bordbar E, Malekzadeh M, Ardekani MT, Doroudchi M, Ghaderi A. Serum levels of G-CSF and IL-7 in Iranian breast cancer patients. Asian Pacific journal of cancer prevention : APJCP. 2012;13(10):5307-12.

44.          Bahrani H, Razmkhah M, Ashraf MJ, Tanideh N, Chenari N, Khademi B, et al. Differentiation of adipose-derived stem cells into ear auricle cartilage in rabbits. The Journal of laryngology and otology. 2012;126(8):770-4.

45.          Ashouri E, Dabbaghmanesh MH, Rowhanirad S, Bakhshayeshkaram M, Ranjbar Omrani G, Ghaderi A. Activating KIR2DS5 receptor is a risk for thyroid cancer. Human immunology. 2012;73(10):1017-22.

2011

46.          Toghraie FS, Chenari N, Gholipour MA, Faghih Z, Torabinejad S, Dehghani S, et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit. The Knee. 2011;18(2):71-5.

47.          Sarvari J, Mojtahedi Z, Kuramitsu Y, Malek-Hosseini SA, Shamsi Shahrabadi M, Ghaderi A, et al. Differential expression of haptoglobin isoforms in chronic active hepatitis, cirrhosis and HCC related to HBV infection. Oncology letters. 2011;2(5):871-7.

48.          Razmkhah M, Jaberipour M, Ghaderi A. Bcl-2 and Fas expressions correlate with proliferative specificity of adipose-derived stem cells (ASCs) in breast cancer. Immunological investigations. 2011;40(3):290-8.

49.          Razmkhah M, Jaberipour M, Erfani N, Habibagahi M, Talei AR, Ghaderi A. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response? Cellular immunology. 2011;266(2):116-22.

50.          Mojtahedi Z, Safaei A, Yousefi Z, Ghaderi A. Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes. Omics : a journal of integrative biology. 2011;15(6):409-18.

51.          Mojtahedi Z, Khademi B, Hashemi SB, Abtahi SM, Ghasemi MA, Fattahi MJ, et al. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression. Pathology oncology research : POR. 2011;17(1):7-10.

52.          Jaberipour M, Samsami A, Sahraiian F, Kazerooni T, Hashemi M, Ghaderi A, et al. Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer. Asian Pacific journal of cancer prevention : APJCP. 2011;12(1):163-7.

53.          Jaberipour M, Momtahan M, Najib F, Amooei S, Saidifard F, Ghaderi A, et al. Detection of high-risk human papillomavirus types 16 and 18 but not 33 and 52 in external genital warts from Iranian females. Asian Pacific journal of cancer prevention : APJCP. 2011;12(3):771-4.

54.          Haghshenas MR, Naeimi S, Talei A, Ghaderi A, Erfani N. Program death 1 (PD1) haplotyping in patients with breast carcinoma. Molecular biology reports. 2011;38(6):4205-10.

55.          Golmoghaddam H, Pezeshki AM, Ghaderi A, Doroudchi M. CD1a and CD1d genes polymorphisms in breast, colorectal and lung cancers. Pathology oncology research : POR. 2011;17(3):669-75.

56.          Ghaderi A. CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iranian journal of immunology : IJI. 2011;8(3):127-49.

57.          Firouzabadi H, Iranpoor N, Ghaderi A. Gelatin as a bioorganic reductant, ligand and support for palladium nanoparticles. Application as a catalyst for ligand- and amine-free Sonogashira-Hagihara reaction. Organic & biomolecular chemistry. 2011;9(3):865-71.

58.          Farjadian S, Sazzini M, Tofanelli S, Castri L, Taglioli L, Pettener D, et al. Discordant patterns of mtDNA and ethno-linguistic variation in 14 Iranian Ethnic groups. Human heredity. 2011;72(2):73-84.


2010

59.          Razmkhah M, Jaberipour M, Hosseini A, Safaei A, Khalatbari B, Ghaderi A. Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma. Cellular immunology. 2010;265(1):80-5.

60.          Rahimifar S, Erfani N, Sarraf Z, Ghaderi A. ctla-4 gene variations may influence cervical cancer susceptibility. Gynecologic oncology. 2010;119(1):136-9.

61.          Mojtahedi Z, Hashemi SB, Khademi B, Karimi M, Haghshenas MR, Fattahi MJ, et al. p53 codon 72 polymorphism association with head and neck squamous cell carcinoma. Brazilian journal of otorhinolaryngology. 2010;76(3):316-20.

62.          Mojtahedi Z, Haghshenas MR, Hosseini SV, Fattahi MJ, Ghaderi A. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Indian journal of cancer. 2010;47(1):31-4.

63.          Mahjour SB, Ghaffarpasand F, Fattahi MJ, Ghaderi A, Fotouhi Ghiam A, Karimi M. Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in southern iran. Pathology oncology research : POR. 2010;16(4):579-82.

64.          Khaghanzadeh N, Erfani N, Ghayumi MA, Ghaderi A. CTLA4 gene variations and haplotypes in patients with lung cancer. Cancer genetics and cytogenetics. 2010;196(2):171-4.

65.          Jaberipour M, Habibagahi M, Hosseini A, Habibabad SR, Talei A, Ghaderi A. Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer. Pathology oncology research : POR. 2010;16(4):547-51.

66.          Jaberipour M, Habibagahi M, Hosseini A, Abbasi M, Sobhani-Lari A, Talei A, et al. Detection of B cell lymphoma 2, tumor protein 53, and FAS gene transcripts in blood cells of patients with breast cancer. Indian journal of cancer. 2010;47(4):412-7.

67.          Erfani N, Razmkhah M, Ghaderi A. Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer. Cancer investigation. 2010;28(8):828-32.

68.          Dehaghani AS, Zamanpour T, Naeimi S, Sameni S, Robati M, Ghaderi A. Genetic variation in TGF-beta 1 gene promoter and risk of gestational trophoblastic disease. The Journal of reproductive medicine. 2010;55(3-4):151-6.

2009

69.          Yousefipour G, Erfani N, Momtahan M, Moghaddasi H, Ghaderi A. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Acta neurologica Scandinavica. 2009;120(6):424-9.

70.          Vasei M, Modjtahedi H, Ale-Booyeh O, Mosallaei A, Kajbafzadeh AM, Shahriari M, et al. Amplification and expression of EGFR and ERBB2 in Wilms tumor. Cancer genetics and cytogenetics. 2009;194(2):88-95.

71.          Varamini P, Soltani M, Ghaderi A. Cell cycle analysis and cytotoxic potential of Ruta graveolens against human tumor cell lines. Neoplasma. 2009;56(6):490-3.

72.          Varamini P, Javidnia K, Soltani M, Mehdipour AR, Ghaderi A. Cytotoxic activity and cell cycle analysis of quinoline alkaloids isolated from Haplophyllum canaliculatum Boiss. Planta medica. 2009;75(14):1509-16.

73.          Senemar S, Doroudchi M, Pezeshki AM, Bazrgar M, Torab-Jahromi A, Ghaderi A. Frequency of cystathionine beta-synthase 844INS68 polymorphism in Southern Iran. Molecular biology reports. 2009;36(2):353-6.

74.          Samsami Dehaghani A, Shahriary K, Kashef MA, Naeimi S, Fattahi MJ, Mojtahedi Z, et al. Interleukin-18 gene promoter and serum level in women with ovarian cancer. Molecular biology reports. 2009;36(8):2393-7.

75.          Sameni S, Ghayumi MA, Mortazavi G, Faghih Z, Kashef MA, Ghaderi A. Lack of association between interleukin-13 gene polymorphisms (-1055 C/T and +2044 G/A) in Iranian patients with lung cancer. Molecular biology reports. 2009;36(5):1001-5.

76.          Rezaei Z, Firouzabadi H, Iranpoor N, Ghaderi A, Jafari MR, Jafari AA, et al. Design and one-pot synthesis of alpha-aminophosphonates and bis(alpha-aminophosphonates) by iron(III) chloride and cytotoxic activity. European journal of medicinal chemistry. 2009;44(11):4266-75.

77.          Mousavi Niri N, Jaberipour M, Razmkhah M, Ghaderi A, Habibagahi M. Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation. Iranian journal of immunology : IJI. 2009;6(4):186-94.

78.          Khalili-Azad T, Razmkhah M, Ghiam AF, Doroudchi M, Talei AR, Mojtahedi Z, et al. Association of interleukin-18 gene promoter polymorphisms with breast cancer. Neoplasma. 2009;56(1):22-5.

79.          Haghshenas MR, Hosseini SV, Mahmoudi M, Saberi-Firozi M, Farjadian S, Ghaderi A. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. Journal of gastroenterology and hepatology. 2009;24(6):1119-22.

80.          Fattahi MJ, Mojtahedi Z, Karimaghaee N, Talei AR, Banani SJ, Ghaderi A. Analysis of BRCA1 and BRCA2 mutations in southern Iranian Breast cancer patients. Archives of Iranian medicine. 2009;12(6):584-7.

81.          Farjadian S, Ota M, Inoko H, Ghaderi A. The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism. Molecular biology reports. 2009;36(7):1943-50.

82.          Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, Ghaderi A. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study. Acta oncologica (Stockholm, Sweden). 2009;48(7):971-6.

83.          Faghih Z, Erfani N, Razmkhah M, Sameni S, Talei A, Ghaderi A. Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer. Molecular biology reports. 2009;36(7):1923-8.

84.          Dehaghani AS, Rad NR, Fattahi MJ, Khadang B, Kashef MA, Sarraf Z, et al. Investigation of soluble HER2 and transforming growth factor Beta-1 serum levels in gestational trophoblastic disease. Pathology oncology research : POR. 2009;15(1):37-40.

85.          Dehaghani AS, Kashef MA, Ghaemenia M, Sarraf Z, Khaghanzadeh N, Fattahi MJ, et al. PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases. The Journal of reproductive medicine. 2009;54(1):25-31.

86.          Borhani Haghighi A, Ittehadi H, Nikseresht AR, Rahmati J, Poorjahromi SG, Pourabbas B, et al. CSF levels of cytokines in neuro-Behcet's disease. Clinical neurology and neurosurgery. 2009;111(6):507-10.

87.          Amirghofran Z, Jalali SA, Ghaderi A, Hosseini SV. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer. Cancer genetics and cytogenetics. 2009;190(1):21-5.

88.          Alborzi S, Tavazoo F, Dehaghani AS, Ghaderi A, Alborzi M. Determination of antiovarian antibodies after laparoscopic ovarian electrocauterization in patients with polycystic ovary syndrome. Fertility and sterility. 2009;91(4):1159-63.

2008

89.          Tamizifar B, Lankarani KB, Naeimi S, Rismankar Zadeh M, Taghavi A, Ghaderi A. Promoter polymorphism of transforming growth factor-beta1 gene and ulcerative colitis. World journal of gastroenterology : WJG. 2008;14(2):243-7.

90.          Khademi B, Razmkhah M, Erfani N, Gharagozloo M, Ghaderi A. SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathology oncology research : POR. 2008;14(1):45-50.

91.          Kashef MA, Dehaghani AS, Naeimi S, Fattahi MJ, Ghaderi A. Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases. The Journal of reproductive medicine. 2008;53(11):853-9.

92.          Farjadian S, Lotfazar M, Ghaderi A. Analysis of human leukocyte antigen class II gene polymorphism in Iranian patients with Papillon-Lefevre syndrome: a family study. Iranian journal of immunology : IJI. 2008;5(3):171-6.

93.          Emamghoreishi M, Bokaee HR, Keshavarz M, Ghaderi A, Tyndale RF. CYP2A6 allele frequencies in an Iranian population. Archives of Iranian medicine. 2008;11(6):613-7.

94.          Arandi N, Talei A, Erfani N, Ghaderi A. Intercellular adhesion molecule-1 genetic markers (+241G/A and +469A/G) in Iranian women with breast cancer. Cancer genetics and cytogenetics. 2008;183(1):9-13.

95.          Amirghofran Z, Jalali SA, Hosseini SV, Vasei M, Sabayan B, Ghaderi A. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis. Journal of gastrointestinal cancer. 2008;39(1-4):73-8.


2007

96.          Tamizifar B, Bagheri-Lankarani K, Naeemi S, Rismankar-Zadeh M, Taghavi A, Ghaderi A. Polymorphism of the promoter region of C-509T of transforming growth factor-beta1 gene and ulcerative colitis. Archives of Iranian medicine. 2007;10(2):171-5.

97.          Sharifzadeh S, Modjtahedi H, Jedi Tehrani M, Bayat A, Ghaderi A. Production and characterization of a monoclonal antibody against an antigen on the surface of non-small cell carcinoma of the lung. Iranian journal of immunology : IJI. 2007;4(4):206-14.

98.          Mousavi SA, Nikseresht AR, Arandi N, Borhani Haghighi A, Ghaderi A. Intercellular adhesion molecule-1 gene polymorphism in Iranian patients with multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies. 2007;14(12):1397-9.

99.          Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Cancer genetics and cytogenetics. 2007;173(1):38-42.

100.        Kashef S, Ghaedian MM, Rajaee A, Ghaderi A. Dyslipoproteinemia during the active course of systemic lupus erythematosus in association with anti-double-stranded DNA (anti-dsDNA) antibodies. Rheumatology international. 2007;27(3):235-41.

101.        Hadinia A, Hossieni SV, Erfani N, Saberi-Firozi M, Fattahi MJ, Ghaderi A. CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. Journal of gastroenterology and hepatology. 2007;22(12):2283-7.

102.        Farjadian S, Ghaderi A. HLA class II genetic diversity in Arabs and Jews of Iran. Iranian journal of immunology : IJI. 2007;4(2):85-93.

103.        Farjadian S, Ghaderi A. HLA class II similarities in Iranian Kurds and Azeris. International journal of immunogenetics. 2007;34(6):457-63.

104.        Dehaghani AS, Ghiam AF, Hosseini M, Mansouri S, Ghaderi A. Factors influencing serum concentration of CA125 and CA15-3 in Iranian healthy postmenopausal women. Pathology oncology research : POR. 2007;13(4):360-4.

2006

105.        Rajaee A, Ebrahimi A, Ghiam AF, Kalantari T, Ghaderi A. Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients. Rheumatology international. 2006;26(8):687-92.

106.        Pezeshki A, Sari-Aslani F, Ghaderi A, Doroudchi M. p53 codon 72 polymorphism in basal cell carcinoma of the skin. Pathology oncology research : POR. 2006;12(1):29-33.

107.        Naeimi S, Ghiam AF, Mojtahedi Z, Dehaghani AS, Amani D, Ghaderi A. Interleukin-18 gene promoter polymorphisms and recurrent spontaneous abortion. European journal of obstetrics, gynecology, and reproductive biology. 2006;128(1-2):5-9.

108.        Mojtahedi Z, Naeimi S, Farjadian S, Omrani GR, Ghaderi A. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association. 2006;23(3):235-9.

109.        Mojtahedi Z, Ahmadi SB, Razmkhah M, Azad TK, Rajaee A, Ghaderi A. Association of chemokine receptor 5 (CCR5) delta32 mutation with Behcet's disease is dependent on gender in Iranian patients. Clinical and experimental rheumatology. 2006;24(5 Suppl 42):S91-4.

110.        Lankarani KB, Karbasi A, Kalantari T, Yarmohammadi H, Saberi-Firoozi M, Alizadeh-Naeeni M, et al. Analysis of cytotoxic T lymphocyte associated antigen 4 gene polymorphisms in patients with ulcerative colitis. Journal of gastroenterology and hepatology. 2006;21(2):449-53.

111.        Farjadian S, Moqadam FA, Ghaderi A. HLA class II gene polymorphism in Parsees and Zoroastrians of Iran. International journal of immunogenetics. 2006;33(3):185-91.

112.        Farjadian S, Ghaderi A. Iranian Lurs Genetic Diversity: An Anthropological View Based on HLA Class II Profiles. Iranian journal of immunology : IJI. 2006;3(3):106-13.

113.        Faramarzi A, Shamseddin A, Ghaderi A. IgM, IgG Serum Levels and Lymphocytes Count before and after Adenotonsillectomy. Iranian journal of immunology : IJI. 2006;3(4):187-91.

114.        Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, et al. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer genetics and cytogenetics. 2006;165(2):114-20.

115.        Almasi S, Erfani N, Mojtahedi Z, Rajaee A, Ghaderi A. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population. Genes and immunity. 2006;7(5):401-6.

2005

116.        Samsami Dehaghani A, Doroudchi M, Kalantari T, Pezeshki AM, Ghaderi A. Heterozygosity in CTLA-4 gene and severe preeclampsia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2005;88(1):19-24.

117.        Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer letters. 2005;225(2):261-6.

118.        Razmkhah M, Doroudchi M, Ghayumi SM, Erfani N, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung cancer (Amsterdam, Netherlands). 2005;49(3):311-5.

119.        Naghibalhossaini F, Pakdel A, Ghaderi AA, Saberi Firoozi M. Effective production of carcinoembryonic antigen by conversion of the membrane-bound into a recombinant secretory protein by site-specific mutagenesis. Pathology oncology research : POR. 2005;11(4):211-7.

120.        Mojtahedi Z, Omrani GR, Doroudchi M, Ghaderi A. CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians. Diabetes research and clinical practice. 2005;68(2):111-6.

121.        Mojtahedi Z, Ghaderi A. Role of interleukin-18 in allergy and autoimmunity: an explanation for the hygiene hypothesis. Medical hypotheses. 2005;65(2):305-7.

122.        Mojtahedi Z, Farjadian S, Ghaderi A. Does autoantigen administration inhibit recurrence of type 1 diabetes in transplanted islets? Medical hypotheses. 2005;64(5):986-8.

123.        Ghayumi SM, Mehrabi S, Doroudchi M, Ghaderi A. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients. Pathology oncology research : POR. 2005;11(4):236-41.

124.        Gharagozloo M, Ghaderi A. Coincident natural selection of CCR5Delta32 and C282Y in Europe: to be or not to be? Journal of genetics. 2005;84(1):47-8.

125.        Gharagozloo M, Doroudchi M, Farjadian S, Pezeshki AM, Ghaderi A. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population. Immunology letters. 2005;96(2):277-81.

2004

126.        Sharifzadeh S, Owji SM, Pezeshki AM, Malek-Hoseini Z, Kumar PV, Ghayumi SM, et al. Establishment and characterization of a human large cell lung cancer cell line with neuroendocrine differentiation. Pathology oncology research : POR. 2004;10(4):225-30.

127.        Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast cancer research and treatment. 2004;86(1):1-7.

128.        Farjadian S, Naruse T, Kawata H, Ghaderi A, Bahram S, Inoko H. Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan. Tissue antigens. 2004;64(5):581-7.

129.        Doroudchi M, Dehaghani AS, Ghaderi A. Preferential placental transfer of Helicobacter pylori specific IgG. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2004;16(5):297-301.

130.        Amani D, Zolghadri J, Dehaghani AS, Pezeshki AM, Ghaderi A. The promoter region (-800, -509) polymorphisms of transforming growth factor-beta1 (TGF-beta1) gene and recurrent spontaneous abortion. Journal of reproductive immunology. 2004;62(1-2):159-66.


2003

131.        Samsami Dehaghani A, Doroudchi M, Ghaderi A. Placental transfer of tetanus-specific immunoglobulin G in Iranian mothers. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2003;14(3):147-50.

132.        Kalantari T, Mostafavi H, Pezeshki AM, Farjadian S, Doroudchi M, Yeganeh F, et al. Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' disease. Autoimmunity. 2003;36(5):313-6.

133.        Farjadian S, Asadi E, Doroudchi M, Dehaghani AS, Tabei SZ, Kumar VP, et al. High risk HPV types in southern Iranian patients with cervical cancer. Pathology oncology research : POR. 2003;9(2):121-5.

134.        Doroudchi M, Samsami Dehaghani A, Emad K, Ghaderi A. Placental transfer of rubella-specific IgG in fullterm and preterm newborns. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2003;81(2):157-62.

2002

135.        Khademi B, Shirazi FM, Vasei M, Doroudchi M, Gandomi B, Modjtahedi H, et al. The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer letters. 2002;184(2):223-30.

136.        Kazerooni T, Taallom M, Ghaderi AA. Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2002;79(3):217-20.

137.        Gharagozloo M, Doroudchi M, Ghaderi A. Effects of Citrus aurantifolia concentrated extract on the spontaneous proliferation of MDA-MB-453 and RPMI-8866 tumor cell lines. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2002;9(5):475-7.

138.        Ghaderi A, Vasei M, Maleck-Hosseini SA, Gharesi-Fard B, Khodami M, Doroudchi M, et al. The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma. Pathology oncology research : POR. 2002;8(4):252-6.

139.        Dehaghani AS, Amirzargar A, Farjadian S, Ghaderi A. HLA-DQBl alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients. Pathology oncology research : POR. 2002;8(1):58-61.

2001

140.        Pezeshki AM, Farjadian S, Talei A, Vasei M, Gharesi-Fard B, Doroudchi M, et al. p53 gene alteration and protein expression in Iranian women with infiltrative ductal breast carcinoma. Cancer letters. 2001;169(1):69-75.

141.        Gharagozloo M, Ghaderi A. Immunomodulatory effect of concentrated lime juice extract on activated human mononuclear cells. Journal of ethnopharmacology. 2001;77(1):85-90.

142.        Ghaderi A, Talei A, Gharesi-Fard B, Farjadian SH, Amirzargar A, Vasei M. HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer. Pathology oncology research : POR. 2001;7(1):39-41.

143.        Ghaderi A, Talei A, Farjadian S, Mosalaei A, Doroudchi M, Kimura H. Germline BRCA1 mutations in Iranian women with breast cancer. Cancer letters. 2001;165(1):87-94.

144.        Doroudchi M, Dehaghani AS, Emad K, Ghaderi AA. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2001;7(1-2):128-38.

2000 and ...

145.        Doroudchi M, Kremer K, Basiri EA, Kadivar MR, Van Soolingen D, Ghaderi AA. IS6110-RFLP and spoligotyping of Mycobacterium tuberculosis isolates in Iran. Scandinavian journal of infectious diseases. 2000;32(6):663-8.

146.        Amirghofran Z, Ghaderi AA. Characterization of a murine monoclonal antibody reactive with a leukocyte common antigen and its application to bone marrow transplantation. Transplantation proceedings. 1995;27(5):2657-8.

147.        Amirghofran Z, Ghaderi AA. Cross-linking of CD38 molecules induced expression of interleukin-2 receptor (IL-2R) and HLA-DR on human thymocytes. Roumanian archives of microbiology and immunology. 1995;54(4):265-70.

148.        Ghaderi AA, Gaudernack G, Stanworth DR. Cross-linking of a sequential epitope within the beta-chain of HLA-DR/DP molecules suppressing B lymphocyte growth and inducing homotypic cell aggregation. Immunology letters. 1994;39(2):113-9.

149.        Ghaderi AA, Stanworth DR. Production and characterization of two murine monoclonal antibodies directed against epitopes exclusive to soluble fragments of Fc epsilon RII/CD23. European journal of immunology. 1993;23(11):2909-15.

150.        Ghaderi AA, Stanworth DR. Epitope mapping of the site(s) of binding of Fc epsilon RII/CD23 within human IgE. Determination of the B lymphocyte-binding sites by use of synthetic peptides and anti-peptide antibodies representative of linear Fc sequences. Molecular immunology. 1993;30(18):1655-63.

151.        Ghaderi AA, Stanworth DR. Affinity-purified soluble Fc epsilon RII/CD23 derived from a culture supernatant of an EBV-immortalized B-cell line induced a monophasic fever in rabbits. Immunology. 1991;73(4):510-1.

 
Shiraz University of Medical Sciences
Shiraz Institute for Cancer Research (ICR)
P.O. Box: 71345-3119
Tel: +98(0)71 32303687
Fax: +98(0)71 32304952